In 2024, Fresenius Medical Care completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Fresenius Medical Care has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 360,803a | 387,049a | 258,400b | |
Total Scope 2 | ||||
Market-Based | 326,636a | 405,340a | 401,100b | |
Location-Based | 450,611a | 470,806a | 472,900b | |
Total Scope 3 | 2,993,388a | 3,083,700b | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 17.9315a | 17.9758a | 12.4953b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Fresenius Medical Care amounted to 811,414 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Fresenius Medical Care decreased by 5.41%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of Fresenius Medical Care were 360,803 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Fresenius Medical Care's Scope 1 emissions have increased by 58.73%, reflecting a rising long-term trend in Scope 1 emissions over time.ac
Compared to the previous year (2023), Fresenius Medical Care's Scope 1 emissions decreased by 6.78%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, Fresenius Medical Care reported Scope 2 greenhouse gas (GHG) emissions of 326,636 tCO₂e using the market-based method and 450,611 tCO₂e using the location-based method.a
Since 2019, Fresenius Medical Care's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 17.65%, reflecting a declining long-term trend in Scope 2 emissions over time.ad
Compared to the previous year (2023), Fresenius Medical Care's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Fresenius Medical Care's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Fresenius Medical Care reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Fresenius Medical Care reported 2,993,388 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Fresenius Medical Care includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Fresenius Medical Care reported total Scope 3 emissions of 2,993,388 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 69.97% of these emissions originated from upstream activities such as purchased goods and capital goods, while 30.03% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), Fresenius Medical Care's Scope 3 emissions remained relatively stable, indicating that Fresenius Medical Care's emissions have plateaued with no significant change in its value chain footprint.ab
In 2024, Fresenius Medical Care reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to Fresenius Medical Care's Scope 3 emissions were:a
In 2024, Fresenius Medical Care reported Scope 1 greenhouse gas (GHG) emissions of 360,803 tCO₂e and total revenues of USD 20,121 millions. This translates into an emissions intensity of 17.93 tCO₂e per millions USD.a
In 2024, Fresenius Medical Care reported a Scope 1 emissions intensity of 17.93 tCO₂e per millions USD. Compared to the peer group median of 9.74, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Fresenius Medical Care ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Fresenius Medical Care among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2024, Fresenius Medical Care reported a total carbon footprint of 3,804,802 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3.47% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.ab
The largest contributor to Fresenius Medical Care's total carbon footprint was Scope 3 emissions, accounting for 78.67% of the company's total carbon footprint, followed by Scope 2 emissions at 11.84%.a